Search Within

Somali C Gavane

Formats
  1. Journal Article (10)
  2. Book Section (9)
  3. Meeting Abstract (4)
  4. Review (1)
Groups
  1. Molecular Imaging and Therapy Service (24)
  2. Radiology, Department of (24)
  3. Department of Medicine (9)
  4. Solid Tumor Oncology Division (7)
  5. Survivorship Research (7)
  6. Biostatistics Service (6)

More Groups

People
  1. Heiko Schoder (17)
  2. Kimiteru Ito (8)
  3. Josef Fox (6)
  4. Steven Larson (6)
  5. Howard Scher (4)
  6. John Humm (4)

More People

Years
  1. 2024 (1)
  2. 2022 (7)
  3. 2020 (1)
  4. 2018 (1)
  5. 2017 (1)
  6. 2016 (3)

More Years

Publications
  1. Nuclear Oncology: From Pathophysiology to Clinical Applications. 3rd ed (7)
  2. Journal of Clinical Oncology (3)
  3. Atlas of PET/CT in Pediatric Patients (2)
  4. International Journal of Radiation Oncology, Biology, Physics (2)
  5. Journal of Nuclear Medicine (2)
  6. Clinical Nuclear Medicine (1)

More Publications

Publishers
  1. Springer (7)
  2. American Society of Clinical Oncology (3)
  3. Elsevier Inc. (3)
  4. Society of Nuclear Medicine (2)
  5. Springer Verlag (2)
  6. American Medical Association (1)

More Publishers

Results (24)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Multifocal osteosarcoma: Unusual presentation and imaging findings
    Journal Article

    Gavane, S.; Price, A. P.; Magnan, H.; Mahajan, S.; Pandit-Taskar, N.
    Clinical Nuclear Medicine (2017)

    Fulltext@MSK | Save
  • Metabolic tumor volume to predict event free survival in patients with relapsed/refractory HL treated with brentuximab vedotin-based salvage therapy
    Meeting Abstract

    Gavane, S. C.; Ito, K.; Moskowitz, C. H.; Moskowitz, A. J.; Schoder, H.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Prospective study of 3′-deoxy-3′-(18)F-fluorothymidine PET for early interim response assessment in advanced-stage B-cell lymphoma
    Journal Article

    Schoder, H.; Zelenetz, A. D.; Hamlin, P.; Gavane, S.; Horwitz, S.; Matasar, M.; Moskowitz, A.; Noy, A.; Palomba, L.; Portlock, C.; more...
    Journal of Nuclear Medicine (2016)

    Fulltext@MSK | Save
  • Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after 90Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0
    Journal Article

    Shady, W.; Kishore, S.; Gavane, S.; Do, R. K.; Osborne, J. R.; Ulaner, G. A.; Gonen, M.; Ziv, E.; Boas, F. E.; Sofocleous, C. T.
    European Journal of Radiology (2016)

    Fulltext@MSK | Save
  • Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography in patients receiving hepatic arterial and systemic chemotherapy for unresectable colorectal liver metastases
    Journal Article

    Correa-Gallego, C.; Gavane, S.; Grewal, R.; Cercek, A.; Klimstra, D. S.; Gewirtz, A. N.; Kingham, T. P.; Fong, Y.; DeMatteo, R. P.; Allen, P. J.; more...
    HPB (2015)

    Fulltext@MSK | Save
  • Utility of (18)F-FDG–PET/CT in soft tissue sarcomas
    Book Section

    Gavane, S.; Cistaro, A.; Schoder, H.
    In Cistaro, A. (Eds.) Atlas of PET/CT in Pediatric Patients (2014)

    Fulltext@MSK | Save
  • Poorly differentiated thyroid carcinoma
    Book Section

    Gavane, S.; Schoder, H.
    In Cistaro, A. (Eds.) Atlas of PET/CT in Pediatric Patients (2014)

    Fulltext@MSK | Save
  • Pathologic correlation of 18F-16 beta-fluoro-5 alpha-dihydrotestosterone (FDHT) and FDG PET in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Feldman, J. L.; Fox, J. J.; Martinez, D. F.; Autio, K. A.; Durack, J. C.; Humm, J.; Schoder, H.; Gavane, S. C.; Curtis, K. R.; Balakirsky, S. M.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Utility of FDG-PET in clinical neuroendocrine prostate cancer
    Journal Article

    Spratt, D. E.; Gavane, S.; Tarlinton, L.; Fareedy, S. B.; Doran, M. G.; Zelefsky, M. J.; Osborne, J. R.
    Prostate (2014)

    Fulltext@MSK | Save
  • Evaluating 18F-16 beta-fluoro-5 alpha-dihydrotestosterone (FDHT) and FDG PET as prognostic biomarkers for patients (pts) treated with abiraterone acetate (AA)
    Meeting Abstract

    Feldman, J. L.; Fox, J. J.; Autio, K. A.; Gavane, S. C.; Heller, G.; Schoder, H.; Humm, J.; Martinez, D. F.; Slovin, S. F.; Scher, H. I.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save